Lesson’s Learned from Building out the Commercial Organization
SK Life Science breaks through Covid barriers to bring epilepsy drug to market
Lutronic’s Focus on Change during the Pandemic
From Big Pharma to Startup: What are the Challenges?
The View from Olympus: How This MedTech Leader Approached the Pandemic
DENTALEZ COO Heather Trombley on Reinvigorating the Company
Seqirus Exec on Vaccine Differentiation
Zimmer Biomet VP on Covering the Territory
How Teleflex Grew its Market Value 4x in 6 Years
Admedus COO David St. Denis on Courage, Commitment and Conversation
Newark, CA, October 17, 2022 (Nasdaq) -- An oncology company spearheaded by big names in biotech, but shrouded in ambiguity raised $261 million in new funding, according to STAT News.
Read full article here.
Merck to Acquire Caraway Therapeutics for $610M
Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr
Memo Therapeutics AG Appoints Erik van den Berg as CEO
Zürich, Switzerland, November 16, 2023 (Business Wire) -- Memo Therapeutics AG (“MTx”), a late-stage biotech firm advancing top-tier therapeutic antibodies, discloses the appointment of Erik van den
Boston Scientific Completes Acquisition of Relievant Medsystems, Inc.
Marlborough, MA, November 17, 2023 (PRNewswire) -- Boston Scientific Corporation (NYSE: BSX) announces the completion of its acquisition of Relievant Medsystems Inc., the sole provider of the FDA-cl
Teva names Richard Francis as CEO
BeiGene finalizes a $1.3B Agreement with Ensem for the CDK2 Inhibitor
Bristol Myers buys Orum's Blood Cancer Therapy for up to $180M
BioMarin Appoints Alexander Hardy President and CEO
Aiolos Bio Launches with $245M Series A
Cordis names Scott Drake as CEO
Inari Acquires LimFlow, a Limb-Saving Device Manufacturer, in a $415M Deal